1. Home
  2. Live Updates
  3. Patent coverage

Page 61 - Patent Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patent coverage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patent Coverage Today - Breaking & Trending Today

Federal Circuit Hints At The Scope Of Government's License Rights - Patent

The Federal Circuit's decision in University of South Florida Board of Trustees v. United States, 22-2248 (Fed. Cir. Feb. 9, 2024) hints at the broad scope of the federal government's license rights under the Bayh-Dole Act. ....

White House , District Of Columbia , United States , Board Of Trustees , University Of South Florida , Federal Circuit , South Florida , Federal Claims , Bayh Dole Act , Mayo Clinic , Executive Branch , Federal Circuit Hints At The Scope Of Governments License Rights , Intellectual Property , Licensing Amp Syndication ,

WSJ Reports On Readers' Views On AI & IP: Uncovering Disapproval Of Current Law - Patent

A few days ago, The Wall Street Journal reported on its readers' views on copyright and other legal issues related to artificial intelligence (AI). ....

Wall Street Journal , Wsj Reports On Readers Amp 39 Views Ai Ip Uncovering Disapproval Of Current Law , Intellectual Property , New Technology ,

Celltrion Submits An ABLA For Actemra® (Tocilizumab) Proposed Biosimilar CT-P47 - Patent

On January 28, 2024 Celltrion announced the submission to the FDA of an aBLA for CT-P47, a proposed biosimilar of Genentech's Actemra® (tocilizumab). ....

United States , Quinn Emanuel Urquhart Sullivan , Livingston Mattesich , Los Angeles , Cowan Liebowitz Latman , Foley Lardner , Obhan Associates , Supreme Court , Intellectual Property , Comparative Guide , Celltrion Submits An Abla For Actemra Xae Tocilizumab Proposed Biosimilar Ct P47 ,

Seagen Requests Director Review Of Unpatentability Decision In Adcetris® Patent PGR - Patent

On February 14, 2024, Seagen requested director review of the PTAB's January 16th Final Written Decision ("FWD") in PGR2021-00030 finding antibody-drug conjugate claims in U.S. Patent No. 10,808,039. ....

April Breyer Menon , Seagen Adcetris , Final Written Decision , Final Written Decision Finding , Seagen Requests Director Review Of Unpatentability Decision In Adcetris Xae Patent Pgr , Intellectual Property ,

PTAB Institutes Celltrion And Biocon IPRs On Regeneron Aflibercept Dosing Patent - Patent

Late last month, a Patent Trial and Appeal Board ("PTAB") panel instituted two petitions that were filed separately by Celltrion and Biocon for inter partes review ("IPR") of Regeneron's U.S. ....

Samsung Bioepis , Co Ltd , Patent Trial , Appeal Board , Samsung Bioepis , Intellectual Property ,